Diagnosis, Oxidative Stress, Vertigo, Central Origin, Vertigo, Peripheral
Conditions
Keywords
Vertigo, Central vertigo, Peripheral vertigo, Thiol/disulfide homeostasis, Ischemia modified albumin, Differential diagnosis
Brief summary
Vertigo is a common complaint in the Emergency Department (ED). The differential diagnosis of central and peripheral vertigo is a difficult issue that directly affects mortality. Magnetic resonance imaging (MRI) is the preferred diagnostic tool, but may not be suitable in all patients due to logistic and economic conditions. In this study, the investigators evaluated the role of thiol/disulfide homeostasis (TDH) parameters and ischemia modified albumin (IMA) levels to assist in the value of being used instead of MRI.
Detailed description
The study was conducted in the ED using a prospective, non-randomized method, and included patients with complaints of acute onset vertigo over 18 years of age and who underwent brain MRI. Pregnant women, smokers, and those with significant neurological signs were excluded. Patients with acute ischemia with MRI were included in the central vertigo group, and patients with normal MRI were included in the peripheral vertigo group. Blood samples for native thiol (NT), total thiol (TT), disulfide, and IMA were collected from all patients at admission. Statistical analyzes were performed with IBM SPSS Statistics for Windows 16.0 Package Program.
Interventions
None listed
Sponsors
Ankara Training and Research Hospital
Ankara City Hospital Bilkent
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
51 Years to 85 Years
Healthy volunteers
No
Inclusion criteria
* Patients with complaint of vertigo * Patients over18 years of age
Exclusion criteria
* Patients contraindicated for MRI due to metal prosthesis or claustrophobia * Patients under 18 years of age * Pregnant patients * Tobacco users * Patients exhibiting significant neurological signs or symptoms such as motor or sensory neurologic deficit, speech disorders, unconsciousness, or seizure * Patients found to have any type of lesion such as a hematoma, mass, cyst, aneurysm, arteriovenous malformation, etc. other than ischemic infarcts on MRI * Patients with an ischemic lesion other than posterior fossa lesions * Patients with any type of infection, including upper respiratory tract and ear infections * Patients previously diagnosed with peripheral vertigo * Patients where the cause of lightheadedness was blood pressure disorders, cardiac ischemic and arrhythmic disorders, thromboembolic diseases, metabolic disorders, trauma, etc. rather than central and peripheral vertigo.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Oxidative stress | 6 months | Thiol/disulphide homeostasis |
| Ischemic status | 6 months | Ischemia modified albumin |
Countries
Turkey (Türkiye)
Outcome results
None listed